NASDAQ$PLRX

Pliant Therapeutics Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

PLRX Q4 2023 — extraction skipped

Pliant Therapeutics Inc filed Form 8-K (accession 0001746473-24-000041) for Q4 2023, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.

  • Form 8-K filed; press release body not parseable here.
  • Reason: no headline numerics found by parser nor by Financial Datasets fallback.
  • Numerics rely on the Financial Datasets fallback.

Headline financials

Total Revenue

$0.00

Previous: $1.97M-100.0%
EPS (adj)

-$0.69

Previous: -$0.72+4.2%
Capital Expenditures

-$61K

Previous: $166K-136.7%
Net Income

-$41.1M

Previous: -$34.6M-18.8%
Operating Income

-$47M

Previous: -$37.4M-25.8%
Gross Profit

-$464K

Previous: $912K-150.9%
R&D Expense

$32.7M

No prior period
Stock-Based Comp

$9.15M

Previous: $10.9M-15.7%

Revenue & EPS history

Pliant Therapeutics · Revenue · Quarterly

$0

Q4 2023-100%vs Q4 2022
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-1.8%

Avg return

Earnings day

-2.4%

Avg return

5 days after

-4.2%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+12.1%

Q3 2020

Best reaction

-11.7%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+0.8%-4.2%-4.2%
Q3 2025+3.3%+17.6%-20.9%
Q1 2025-1.5%-2.9%-1.4%
Q4 2024-11.7%+17.4%-5.1%
Q3 2024-4.5%-12.0%-6.4%
Q2 2024-6.5%-9.6%-1.8%
Q1 2024-1.4%-1.2%-13.4%
Q4 2023-7.8%-4.8%-13.4%
Q3 2023-8.0%-12.4%-2.7%
Q2 2023+3.4%-0.9%-9.5%
Q1 2023+4.2%-0.0%+3.0%
Q4 2022-10.9%-9.4%-17.6%
Q3 2022-6.5%-6.7%-14.5%
Q2 2022+11.9%+12.6%+6.2%
Q1 2022-6.8%-1.8%+40.5%
Q4 2021+3.7%-9.9%-26.6%
Q3 2021-4.0%-3.2%-17.9%
Q2 2021-6.5%-12.4%-15.7%
Q1 2021-0.1%-14.7%-3.1%
Q4 2020+4.6%+2.5%-19.9%
Q3 2019+12.1%+9.9%+21.2%
Q3 2020+12.1%+9.9%+21.2%
Q2 2020-8.5%-8.2%-1.2%
Q4 2019-8.5%-8.2%-1.2%
Q2 2019-8.5%-8.2%-1.2%
Q1 2020
Q1 2019
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro